23.56
price up icon3.51%   0.80
pre-market  Vorhandelsmarkt:  22.79   -0.77   -3.27%
loading

Immunovant Inc Aktie (IMVT) Neueste Nachrichten

pulisher
01:44 AM

Immunovant Announces Pricing of $550 Million Common Stock Financing - The Manila Times

01:44 AM
pulisher
01:29 AM

Immunovant (Nasdaq: IMVT) raises $550M to support potential IMVT-1402 Graves’ launch - Stock Titan

01:29 AM
pulisher
Dec 10, 2025

Immunovant (IMVT) Down 0.6% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

Dec 10, 2025
pulisher
Dec 06, 2025

55,524 Shares in Immunovant, Inc. $IMVT Purchased by Capital Fund Management S.A. - MarketBeat

Dec 06, 2025
pulisher
Dec 05, 2025

Two Seas Capital LP Boosts Stake in Immunovant, Inc. $IMVT - MarketBeat

Dec 05, 2025
pulisher
Dec 04, 2025

Insider Selling: Immunovant (NASDAQ:IMVT) Director Sells 15,000 Shares of Stock - MarketBeat

Dec 04, 2025
pulisher
Dec 04, 2025

Immunovant, Inc. (NASDAQ:IMVT) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Dec 04, 2025
pulisher
Dec 03, 2025

Immunovant Executives Sell Shares Under Trading Plans - TradingView

Dec 03, 2025
pulisher
Dec 03, 2025

Dir Fromkin Surrenders 22,249 Of Immunovant Inc [IMVT] - TradingView

Dec 03, 2025
pulisher
Dec 02, 2025

Is Immunovant (IMVT) Overvalued? Taking Stock of Its Premium Price-to-Book Multiple - Yahoo Finance

Dec 02, 2025
pulisher
Dec 01, 2025

Oppenheimer Maintains Outperform Rating on Immunovant (IMVT) Following Q2 2026 Earnings - MSN

Dec 01, 2025
pulisher
Dec 01, 2025

Immunovant (IMVT) Stock Analysis Report | Financials & Insights - Benzinga

Dec 01, 2025
pulisher
Nov 30, 2025

XTX Topco Ltd Buys New Holdings in Immunovant, Inc. $IMVT - MarketBeat

Nov 30, 2025
pulisher
Nov 29, 2025

Tejara Capital Ltd Raises Position in Immunovant, Inc. $IMVT - MarketBeat

Nov 29, 2025
pulisher
Nov 29, 2025

Immunovant, Inc. $IMVT Shares Acquired by Geode Capital Management LLC - MarketBeat

Nov 29, 2025
pulisher
Nov 28, 2025

(IMVT) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com

Nov 28, 2025
pulisher
Nov 28, 2025

12 Best Short Squeeze Stocks to Buy Right Now - Insider Monkey

Nov 28, 2025
pulisher
Nov 26, 2025

Immunovant’s Earnings Call Highlights Clinical Success and Financial Strength - MSN

Nov 26, 2025
pulisher
Nov 26, 2025

Officer Geffner Files To Sell 50,000 Of Immunovant Inc [IMVT] - TradingView

Nov 26, 2025
pulisher
Nov 26, 2025

Officer Geffner Files To Sell 103,897 Of Immunovant Inc [IMVT] - TradingView

Nov 26, 2025
pulisher
Nov 25, 2025

Immunovant (IMVT): Assessing Valuation Following R&D Leadership Restructuring and CMO Departure - Sahm

Nov 25, 2025
pulisher
Nov 24, 2025

JPMorgan Lowers PT on Immunovant (IMVT) to $33 From $37 - MSN

Nov 24, 2025
pulisher
Nov 23, 2025

Have Insiders Sold Immunovant Shares Recently? - simplywall.st

Nov 23, 2025
pulisher
Nov 22, 2025

Immunovant Restructures R&D Leadership with CMO Departure - The Globe and Mail

Nov 22, 2025
pulisher
Nov 22, 2025

Immunovant COO Gloria sells $298k in shares By Investing.com - Investing.com Nigeria

Nov 22, 2025
pulisher
Nov 21, 2025

Immunovant COO Gloria sells $298k in shares - Investing.com

Nov 21, 2025
pulisher
Nov 21, 2025

Immunovant Insider Sold Shares Worth $298,237, According to a Recent SEC Filing - MarketScreener

Nov 21, 2025
pulisher
Nov 21, 2025

Immunovant COO Gloria Melanie Sells Shares to Cover Tax Obligations - TradingView

Nov 21, 2025
pulisher
Nov 21, 2025

[Form 4] Immunovant, Inc. Insider Trading Activity - Stock Titan

Nov 21, 2025
pulisher
Nov 21, 2025

[8-K] Immunovant, Inc. Reports Material Event | IMVT SEC FilingForm 8-K - Stock Titan

Nov 21, 2025
pulisher
Nov 21, 2025

Immunovant, Inc. Announces Cessation of Michael Geffner, M.D., M.B.A. as Chief Medical Officer, Effective November 21, 2025 - marketscreener.com

Nov 21, 2025
pulisher
Nov 19, 2025

How analysts rate Immunovant Inc. stock todayInsider Selling & Technical Entry and Exit Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Immunovant Inc. stock outperform value stocksTrade Exit Summary & Weekly Breakout Watchlists - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Immunovant Inc. stock affected by interest rate hikesJuly 2025 Gainers & Stepwise Trade Signal Implementation - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Can swing trading help recover from Immunovant Inc. losses2025 Pullback Review & Accurate Intraday Trading Signals - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

How Immunovant Inc. stock performs after earningsJuly 2025 Spike Watch & Community Consensus Trade Signals - newser.com

Nov 18, 2025
pulisher
Nov 17, 2025

Responsive Playbooks and the IMVT Inflection - news.stocktradersdaily.com

Nov 17, 2025
pulisher
Nov 16, 2025

Is Immunovant Inc. meeting your algorithmic filter criteriaPortfolio Value Summary & Safe Capital Growth Stock Tips - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Is Immunovant Inc. stock oversold or undervalued2025 Price Momentum & Weekly High Potential Alerts - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Key resistance and support levels for Immunovant Inc.Global Markets & Risk Adjusted Swing Trade Ideas - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Will Immunovant Inc. stock go up soonTrade Performance Summary & Free Low Drawdown Momentum Trade Ideas - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

Sentiment analysis tools applied to Immunovant Inc.Weekly Stock Report & Low Risk High Win Rate Stock Picks - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Why Immunovant Inc. stock is popular among millennials2025 Technical Overview & Community Consensus Picks - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Why Immunovant Inc. stock is recommended by analystsWeekly Trade Analysis & Consistent Income Trade Ideas - newser.com

Nov 15, 2025
pulisher
Nov 14, 2025

Connor Clark & Lunn Investment Management Ltd. Has $7.18 Million Holdings in Immunovant, Inc. $IMVT - MarketBeat

Nov 14, 2025
pulisher
Nov 13, 2025

How institutional ownership impacts Immunovant Inc. stockMarket Activity Summary & Daily Profit Maximizing Trade Tips - newser.com

Nov 13, 2025
$38.26
price up icon 0.45%
$95.17
price up icon 0.01%
$31.24
price up icon 1.00%
$95.73
price down icon 0.12%
biotechnology ONC
$322.68
price up icon 1.25%
$189.85
price down icon 2.22%
Kapitalisierung:     |  Volumen (24h):